13F

Stock

Allogene Therapeutics, Inc.

ALLO · held by 2 managers

Reported value

$397.4K

Holders

2

+1 new · −0 exited

Holders’ est. mark

−$335.4K

Price effect on 1 books still in the name

Largest holder

$396.6K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC170.2K$396.6K−$335.4KCut−$304K
Leonteq Securities AG351$818New

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.